Amedisys Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Amedisys heeft een totaal eigen vermogen van $1.2B en een totale schuld van $358.6M, wat de schuld-eigenvermogensverhouding op 30.4% brengt. De totale activa en totale passiva bedragen respectievelijk $2.1B en $938.5M. De EBIT Amedisys is $209.1M waardoor de rentedekking 7.8 is. Het heeft contanten en kortetermijnbeleggingen van $149.9M.
Belangrijke informatie
30.4%
Verhouding schuld/eigen vermogen
US$358.59m
Schuld
| Rente dekkingsratio | 7.8x |
| Contant | US$149.88m |
| Aandelen | US$1.18b |
| Totaal verplichtingen | US$938.48m |
| Totaal activa | US$2.12b |
Recente financiële gezondheidsupdates
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Recent updates
Final Push For Amedisys As UnitedHealth Awaits Regulatory Clearance
Nov 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $555.9M ) AMED } overtreffen de korte termijn passiva ( $480.0M ).
Langlopende schulden: De kortetermijnactiva AMED ( $555.9M ) overtreffen de langetermijnschulden ( $458.5M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 17.7% ) AMED wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van AMED is de afgelopen 5 jaar gedaald van 48.1% naar 30.4%.
Schuldendekking: De schuld van AMED wordt goed gedekt door de operationele kasstroom ( 26.8% ).
Rentedekking: De rentebetalingen op de schuld van AMED worden goed gedekt door EBIT ( 7.8 x dekking).